Cello Group Plc provided earnings update for the year ended 31 December 2017. The group traded well in 2017, with continued strong overall and like-for-like growth from Cello Health. The Group has also successfully integrated two US acquisitions into Cello Health. Accordingly, the Group expects to report a full year result in line with expectations. Overall operating profit margins are slightly lower than in 2016, reflecting the substantial addition of professional resource in the year to enable the business to meet its full year gross profit growth target, as well as its longer-term growth goals.